Emerging diabetes therapies: Bringing back the β-cells

BACKGROUND: Stem cell therapies are finally coming of age as a viable alternative to pancreatic islet transplantation for the treatment of insulin-dependent diabetes. Several clinical trials using human embryonic stem cell (hESC)-derived β-like cells are currently underway, with encouraging prelimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, G., Qadir, M.M.F., Mauvais-Jarvis, F., Vetere, A., Shoba, V., Modell, A.E., Pastori, R.L., Russ, H.A., Wagner, B.K., Dominguez-Bendala, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987999/
https://www.ncbi.nlm.nih.gov/pubmed/35331962
http://dx.doi.org/10.1016/j.molmet.2022.101477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987999/
https://www.ncbi.nlm.nih.gov/pubmed/35331962
http://dx.doi.org/10.1016/j.molmet.2022.101477

Ejemplares similares